Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) that activates GHRH receptors within the anterior pituitary, while Ipamorelin is a highly selective growth hormone secretagogue that activates the ghrelin (GHS-R1a) receptor
Based on the data from population-based registries now available through the Office for Cancer Registry of the National Cancer Center China, about 3,929,000 new cancer cases and 2,388,000 cancer-related deaths were reported in China in 2015 [2]
The STEP 5 trial demonstrated that continued treatment for 104 weeks maintained weight loss, while the STEP 1 extension study showed that discontinuing semaglutide at 68 weeks led to two-thirds of the weight lost being regained within a year
Frequency: Once per day (subcutaneous), preferably at bedtime
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
